News and Press Releases
Clinigen finalises acquisition of SSI Strategy
London, UK – 21 November 2025 – Clinigen, the global pathfinder accelerating patient access to critical medicines across the lifecycle, today confirmed the close of its acquisition of SSI Strategy,...
Category:
Posted: November 21, 2025
Science Based Targets Initiative confirms CO2e Reduction Targets
Duesseldorf, November 18, 2025 – Gerresheimer, an innovative system and solution provider and a global partner for the pharma, biotech and cosmetic industries, has had its climate targets validated by...
Category:
Posted: November 19, 2025
Food & Farm for Health Project: Building Smarter Air Cargo for Humanitarian Impact
Data-driven air cargo solutions are unlocking new pathways for health, food security, and local empowerment—optimizing pharmaceutical and perishable supply chains to deliver life-saving medicines, strengthen resilience, and support communities, both...
Category:
Posted: November 19, 2025
Bedrijvenzone Machelen Cargo 706 (mailbox 92) 4th floor, Room 411 B - 1830 Machelen
Ypsomed grows by 21% in the first half of 2025/26 in the core business
Burgdorf – Ypsomed continued on its growth trajectory in the first half of the 2025/26 financial year, the Delivery Systems business reached CHF 266.6 million of sales. This represents a 21.0% increase...
Category:
Posted: November 19, 2025
Alzheon to Present Multiple Clinical, Neuroimaging and Modeling Results for Oral Valiltramiprosate/ALZ-801 from Phase 2 and 3 Studies at CTAD Conference in San Diego, December 1–4, 2025
Valiltramiprosate Demonstrates Potential as the First Oral Disease-Modifying Agent to Slow Alzheimer’s Pathology, Indicated by Both Clinical and Volumetric MRI Data Nine Posters Showcase Consistent Benefits of Oral Valiltramiprosate in...
Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: November 19, 2025
Annovis Announces FDA Meeting to Discuss Parkinson’s Disease Dementia Program; Reaffirms FDA Alignment on Pivotal Phase 3 Alzheimer’s Disease Study
18 November 2025 -- Pennsylvania, US -- Annovis Bio, Inc, a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's disease...
Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: November 18, 2025
Stratasys Digital Anatomy Technology Powers First 3D-Printed Eyelid Surgery Training Models in Europe
Addion and the University of Innsbruck advance surgical education with life-like anatomical models that enhance the skill sets of medical professionals and improve patient outcomes 18 November 2025 -- Minnesota,...
Category: Biotechnology, Other, Pharmaceutical
Posted: November 18, 2025
ONWARD Medical Receives FDA 510(k) Clearance Expanding ARC-EX System Indication for Home Use
US FDA clearance now allows use of the ARC-EX System both in clinics and homes ARC-EX is the first and only FDA-cleared technology demonstrated to improve hand strength and sensation...
Category: Biotechnology, Other, Pharmaceutical
Posted: November 17, 2025
Indero Announces Breakthrough Method for Early-Phase Evaluation of Topical Drugs Using Quantitative Gene Expression
Montreal, Canada —Indero is proud to announce the successful completion of an internally funded study that introduces a novel approach to evaluating topical new chemical entities (NCE) in early-phase clinical...
Category:
Posted: November 14, 2025
Smurfit Westrock unveils new clinical packaging facility at Dublin Airport
Smurfit Westrock has inaugurated the first-of-its-kind adherence and clinical packaging facility, reinforcing Ireland’s role at the forefront of global healthcare. Over 40m euros was invested in the brand-new site, which...
Category:
Posted: November 13, 2025
Eisai presents 4-year Leqembi (lecanemab) open-label extension data from post-hoc sub-group analysis at German neurology congress
Clarity AD open-label extension data show that after four years of continuous lecanemab treatment in apolipoprotein E ε4 (ApoE ε4*) non-carriers and heterozygotes, patients continued to accrue benefit relative to...
Category: Clinical Trials, Other, Pharmaceutical
Posted: November 12, 2025
CARBOGEN AMCIS Announces Successful Refinancing and Enhancement of their Syndicated Credit Facilities to Support Continued Growth and Investment
12 November 2025 -- Bubendorf, Switzerland -- CARBOGEN AMCIS, a subsidiary of Dishman Carbogen Amcis, and a global top-tier Contract Development and Manufacturing Organisation (CDMO), today announced the successful refinancing and...
Category: BioManufacturing, Manufacturing and Packing, Other, Pharmaceutical
Posted: November 12, 2025
Integrated DNA Technologies and Beckman Coulter Life Sciences Partner to Advance Cancer Research Through Automated NGS Workflows
Collaboration aims to equip users with complete NGS solution from sample to answer 12 November 2025 -- Colorado and Indiana, US -- Danaher companies Integrated DNA Technologies (IDT), a global leader in...
Category: Biotechnology, Drug Discovery, Other, Pharmaceutical
Posted: November 12, 2025
Sanner achieves EcoVadis Gold status
Bensheim/Germany, November 12, 2025 – Sanner, a leading global manufacturer of healthcare packaging solutions and a contract development and manufacturing organization (CDMO) for medtech products, has achieved the EcoVadis Gold...
Category:
Posted: November 12, 2025
Acuitas Therapeutics to Showcase LNP Delivery Platform at Four Prestigious Conferences in November 2025
29 October 2025 -- British Columbia, Canada -- Acuitas Therapeutics, a global leader in lipid nanoparticle (LNP) delivery systems, today announced its participation in four upcoming conferences in November 2025....
Category: Biotechnology, Clinical Trials, Other, Pharmaceutical
Posted: November 11, 2025
